Radiation therapy and immunotherapy: what is the optimal timing or sequencing?

Area of Science:

• Oncology
• Immunology
• Radiation Oncology

Background:

• Radiotherapy is a standard treatment for locally advanced and oligometastatic tumors.
• Despite advances, tumor progression and recurrence remain challenges.
• Immunotherapy can overcome tumor immune evasion.

Purpose of the Study:

• To review evidence on combining radiotherapy and immunotherapy.
• To elucidate molecular mechanisms of this combination.
• To discuss strategies for optimizing combination therapy sequencing.

Main Methods:

• Review of preclinical studies.
• Analysis of early clinical trial data.
• Discussion of molecular mechanisms and therapeutic strategies.

Main Results:

• Radiotherapy combined with immunotherapy shows potential for improved outcomes.
• This combination can enhance anti-tumor immune responses.
• Synergistic effects are observed in preclinical and early clinical settings.

Conclusions:

• Combining radiotherapy and immunotherapy offers a promising strategy to improve treatment efficacy.
• Optimizing the timing and sequencing of these therapies is crucial for maximal synergy.
• This approach may help overcome tumor immune tolerance and reduce recurrence.